Record Details

CMFRI develops anti-obesity nutraceutical The Hindu dated 28th May 2017

CMFRI Repository

View Archive Info
 
 
Field Value
 
Relation http://eprints.cmfri.org.in/11918/
http://www.thehindu.com/news/cities/Kochi/cmfri-develops-anti-obesity-nutraceutical/article18593838.ece
 
Title CMFRI develops anti-obesity nutraceutical The Hindu dated 28th May 2017
 
Creator CMFRI, Library
 
Subject Library & Information Science
CMFRI News Clippings
 
Description The anti-obesity nutraceutical developed by the Central Marine Fisheries Research Institute (CMFRI) from seaweeds will soon hit the market.

The CMFRI has signed a pact with healthcare group VLCC for the commercial production of the product named Cadalmin Antihypercholesterolemic extract (Cadalmin - ACe), a natural remedy for obesity. A. Gopalakrishnan, director of CMFRI, signed a licence agreement with the director and executive vice president of the firm, said a release. Cadalmin was developed using natural marine bioactive ingredients from selected seaweeds.
 
Publisher The Hindu
 
Date 2017-05-28
 
Type Other
NonPeerReviewed
 
Format text
 
Language en
 
Identifier http://eprints.cmfri.org.in/11918/1/The%20Hindu_28%20May%202017.pdf
CMFRI, Library (2017) CMFRI develops anti-obesity nutraceutical The Hindu dated 28th May 2017. The Hindu.